GlassScriptPhysician profile
Gary Allen Webb
NPI 1598705600
$915.78
in general payments reported to CMS, 2019-2025
13 companies · $63.85 in 2025
The $63.85 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $38.89 · 2020: $130 · 2021: $16.51 · 2023: $440 · 2024: $227 · 2025: $63.85.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $731.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $730.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $161.93 | 2023-2024 | Xarelto |
| Boston Scientific Corporation | $140.86 | 2023 | |
| Silk Road Medical, INC. | $133.44 | 2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| Amgen INC. | $121.83 | 2023 | Otezla |
| Astellas Pharma US INC | $90.05 | 2020 | |
| Glaxosmithkline, LLC. | $70.92 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $52.23 | 2024 | Airsupra, Farxiga |
| Novartis Pharmaceuticals Corporation | $49.80 | 2025 | |
| Otsuka America Pharmaceutical, INC. | $28.33 | 2023 | Rexulti |
| Genentech USA, INC. | $23.97 | 2019 | |
| Lilly USA, LLC | $14.35 | 2024 | Mounjaro |
| Exact Sciences Corporation | $14.05 | 2025 | The Cologuard Plus Collection Kit |
| Teva Pharmaceuticals USA, INC. | $14.02 | 2024 | Austedo Xr |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Webb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.